February 6, 2019

The Early Diagnosis of Alzheimer’s Disease: Discovering Complex Clinical and Pathological Features

Virtual 2021 International Conference on Alzheimer’s & Parkinson’s Diseases

A Challenging Disease Presents Challenging Cases

Dennis Selkoe, MD, introduces the topic of dementia with mixed pathologies by outlining the respective prevalence of several dementia etiologies. He expands by describing the key hypotheses of Alzheimer’s disease pathophysiology and highlighting where overlaps with other dementia pathologies may occur, with a particular focus on vascular pathology and cardiovascular risk factors. The panel members are invited to discuss how cases with mixed pathologies impact their clinical practice before Dr. Selkoe introduces the patient case study, which will be referred to throughout the symposium.

Key Learning Objectives for Biogen’s ADPD 2021 Symposium:

  • Understand how mixed pathologies and varying clinical presentations can affect the early diagnosis of Alzheimer’s disease
  • Gain insights into how comprehensive cognitive assessment tools and fluid and imaging biomarkers can be used to achieve an early diagnosis of Alzheimer’s disease in challenging cases with mixed pathologies
  • Assess the current healthcare system readiness for timely diagnosis of Alzheimer’s disease and management of patients

Disclosure: All panelists received honoraria from Biogen for participation in this symposium.

Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.